Zacks upgrades HealthSouth stock to “buy” — 5 things to know

HealthSouth reported upgraded Zacks rating, according to a Dakota Financial News report.

Advertisement

Here are five quick facts about the company’s stock:

1. Zacks upgraded HealthSouth to “buy” from a “hold” rating.

2. The new price objective from Zacks is $54.

3. There is a suggested potential upside of 24.11 percent from the stock’s previous close.

4. Mid-day last Friday, HealthSouth traded down 3.78 percent, hitting $43.51.

5. HealthSouth’s market cap is $3.81 billion.

More articles on surgery centers:
ASC M&A, real estate today: 3 key thoughts from Jon Vick
The state of ASC business today—5 key thoughts from Ann Geier
24 staffing statistics for orthopedic surgery centers

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.